We have observed
5 EP applications
David Graham Read
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after August 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
IMPROVEMENTS RELATING TO TRAMS
ENHANCED GROWTH INHIBITION OF OSTEOSARCOMA BY CYTOTOXIC POLYMERIZED LIPOSOMAL NANOPARTICLES TARGETING THE ALCAM CELL SURFACE RECEPTOR
PROCESS FOR ISOLATING FUCOIDAN AND LAMINARIN FROM LIVE, HARVESTED SEAWEED
BI-STABLE ELECTROMAGNETIC RELAY WITH X-DRIVE MOTOR